Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer

被引：0
|
作者：
Carole A Spencer
Jonathan S LoPresti
机构：
[1] CA Spencer is Professor of Medicine and JS LoPresti is Associate Professor of Medicine,
[2] University of Southern California,undefined
[3] Los Angeles,undefined
[4] CA,undefined
[5] USA.,undefined
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
As outlined here, measurement of serum thyroglobulin poses a number of technical challenges. These include between-assay biases, sensitivity limitations, and problems caused by thyroglobulin autoantibodies and heterophilic antibodies in patients' serum. As treatment and follow-up strategies for differentiated thyroid cancer evolve, it is important that clinicians are aware of these potential pitfalls.
引用
收藏
页码：223 / 233
页数：10
相关论文
共 50 条
  • [21] Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: Need for thyroglobulin recovery tests
    Bourrel, F
    Hoff, M
    Regis, H
    Courriere, P
    Caron, P
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (09) : 725 - 730
  • [22] Evaluation of the Level of Thyroglobulin Autoantibodies Interfering with Thyroglobulin Measurement in Patients with Differentiated Thyroid Carcinoma
    Latrofa, Francesco
    Ricci, Debora
    Sisti, Eleonora
    Montanelli, Lucia
    Piaggi, Paolo
    Rago, Teresa
    Fiore, Emilio
    Marino, Michele
    Vitti, Paolo
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [23] The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels
    Pellegriti, G
    Scollo, C
    Regalbuto, C
    Attard, M
    Marozzi, P
    Vermiglio, F
    Violi, MA
    Cianci, M
    Vigneri, R
    Pezzino, V
    Squatrito, S
    CLINICAL ENDOCRINOLOGY, 2003, 58 (05) : 556 - 561
  • [24] THYROGLOBULIN IN THE FOLLOW UP OF DIFFERENTIATED THYROID-CANCER
    CASSONI, AM
    HARMER, CL
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 874 - 874
  • [25] Suppressed thyroglobulin performs better than stimulated thyroglobulin in defining an excellent response in patients with differentiated thyroid cancer
    Hu, Hou-Yang
    Liang, Jun
    Zhang, Teng
    Zhao, Teng
    Lin, Yan-Song
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (03) : 247 - 251
  • [26] The influence of thyroglobulin on functional imaging in differentiated thyroid cancer
    Menzel, C
    Zaplatnikov, K
    Diehl, M
    Döbert, N
    Hamscho, N
    Grünwald, F
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (03) : 239 - 243
  • [27] Evaluation of Different Methods for the Detection of Anti- Thyroglobulin Autoantibody: Prevalence of Anti-Thyroglobulin Autoantibody and Anti-Microsomal Autoantibody in Thyroid Cancer Patients
    Chandrakala Gholve
    Archana Damle
    Savita Kulkarni
    Sharmila Banerjee
    MGR. Rajan
    Indian Journal of Clinical Biochemistry, 2022, 37 : 473 - 479
  • [28] Evaluation of Different Methods for the Detection of Anti- Thyroglobulin Autoantibody: Prevalence of Anti-Thyroglobulin Autoantibody and Anti-Microsomal Autoantibody in Thyroid Cancer Patients
    Gholve, Chandrakala
    Damle, Archana
    Kulkarni, Savita
    Banerjee, Sharmila
    Rajan, MGR.
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2022, 37 (04) : 473 - 479
  • [29] Prognostic Significance of Thyroglobulin Antibodies in Differentiated Thyroid Cancer
    Reverter, Jordi L.
    Rosas-Allende, Irene
    Puig-Jove, Carlos
    Zafon, Carles
    Megia, Ana
    Castells, Ignasi
    Pizarro, Eduarda
    Puig-Domingo, Manel
    Granada, M. Luisa
    JOURNAL OF THYROID RESEARCH, 2020, 2020
  • [30] Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma
    Wang, PW
    Wang, ST
    Liu, RT
    Chien, WY
    Tung, SC
    Lu, JC
    Chen, HY
    Lee, CH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12): : 4549 - 4553
12345